Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like Afraxis, Inc. Announces New Imagedirect (SM) Analysis Service March 9, 2017 Bay Area's Nektar Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly July 23, 2017 Varian Medical Systems Gets FDA 510(k) Clearance for Halcyon Treatment System June 28, 2017
